Skip to main content
PLX logo

PLX · Protalix BioTherapeutics, Inc.

Track PLX — free
$2.38 +0.00 (+0.00%) At close · Aug 21
Market Cap
$191.76M
Shares
80.57M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 101
Total Value: $34,599,250
Total Shares: 14,849,490

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 101 13F filers · Δ vs Mar 31, 2026
Top Holder
27.3%
Sep 2023 → Jun 2026 · range 14.0% – 34.8%
+6.3 pts
Top 5
54.1%
Sep 2023 → Jun 2026 · range 50.5% – 65.3%
−5.3 pts
Top 10
70.4%
Sep 2023 → Jun 2026 · range 70.3% – 81.9%
−3.7 pts
HHI
1,010
Sep 2023 → Jun 2026 · range 687 – 1,521
Broadly held−34

Quarterly Activity

vs Mar 31, 2026
New
18
Increased
39
Decreased
16
Sold Out
18
Unchanged
28
Holder count: 0
Institutional value: -7.6%
Shares held: -14.0%

Top Buyers

vs Mar 31, 2026
Institution Added Now Holds Open

Top Sellers

vs Mar 31, 2026
Institution Sold Now Holds Open

Top New Positions

vs Mar 31, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Mar 31, 2026
Institution Previously Held Last Value (USD) Open
Showing 100 of 106
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1006281 CUSIP 74365A309 13F (30d) 91 filings 89 filers Visit website Investor relations